Clinical trial · Interventional
Pilot Study of the Expansion of the DORA Breast Cancer Screening Programme
Pilot Study of the Expansion of the DORA Breast Cancer Screening Programme to Women Aged 45-49 and 70-74 Years
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260926-000001
Summary
Brief summary (as posted)
This prospective interventional clinical study evaluates the feasibility of expanding the Slovenian national breast cancer screening programme DORA to women aged 45-49 years and 70-74 years. Women from selected municipalities will be invited to screening mammography. The study will assess participation rates, the proportion of women referred for additional diagnostic assessment, and other indicators relevant to planning the future expansion of the DORA programme.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Screening | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Screening Mammography | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Screening Mammography
- description
- Women aged 45-49 years and 70-74 years will be invited to undergo screening mammography within the DORA breast cancer screening programme. Screening and any required additional assessment will follow the established DORA programme procedures.
- interventionNames
- Diagnostic Test: Screening Mammography
Primary outcomes (2)
- measure
- Screening Participation Rate
- timeFrame
- From invitation to the scheduled screening mammography appointment, approximately 3-4 weeks
- description
- Percentage of invited women who undergo screening mammography, assessed separately for women aged 45-49 years and 70-74 years.
- measure
- Referral Rate for Additional Assessment
- timeFrame
- At screening mammography, approximately 3-4 weeks after invitation
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 45 Years
- Maximum age
- 74 Years
Show eligibility criteria text
Inclusion Criteria: * Female sex * Age 45-49 years or 70-74 years * Permanent or temporary residence in one of the following municipalities in the Ljubljana regional unit of the Health Insurance Institute of Slovenia: Ljubljana, Grosuplje, Ivančna Gorica, Dobrepolje, Škofljica, Ig, or Medvode * Selected through random sampling from the Central Population Register and invited to participate in the study * Written informed consent to participate. Exclusion Criteria: * No valid compulsory health insurance status or no valid Slovenian health insurance card * Previous diagnosis of invasive or non-invasive breast cancer and registration in the Slovenian Cancer Registry * For women aged 70-74 years: less than 2 years since the previous mammography within the DORA programme.
References
Publications (0)
Data not yet available